OxThera AB, a Stockholm-based privately-held rare disease company, announced on Friday that it has appointed Hugo Petit as its new chief financial officer.

Petit has earlier served as the chief financial officer of MedCap AB. Prior to joining MedCap, Petit held several roles as chief financial officer in small and medium sized companies, and previously acted as a consultant at McKinsey & Company in Stockholm.

Matthew Gantz, CEO of OxThera, said: "It is my pleasure to welcome Hugo as CFO of OxThera. His strong financial and business background in both small and larger companies and recent experience as CFO of a publicly listed life sciences company will help accelerate OxThera's growth as it further builds additional capabilities to support our ambitions."